Toggle navigation
Home
Search
Services
Blog
Contact
About
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David James
Virginia Commonwealth University, Richmond, VA, United States
Search 4 grants from David Mokler
Search grants from Virginia Commonwealth University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Effects of Resistance Training on Appetite Regulation
Mood and Anxiety Subtypes in Anorexia Nervosa: Relevance to Treatment
2novel Embryonic Genes and Liver Development
Endocrine Cancer
A Comparative Study of Homeotic Gene Function in Insects
Recently added grants:
PKD1 signaling in the initiation of pancreatic cancer
Administrative Core
Planning and Evaluation
Catch and Release Immunotoxins: CAR-Bombs for Cancer
Developmental Funds
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DA005260-01A1
Application #
3035088
Study Section
(DABA)
Project Start
1985-11-01
Project End
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Virginia Commonwealth University
Department
Type
Overall Medical
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Related projects
NIH 1986
F32 DA
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David J. / Virginia Commonwealth University
NIH 1985
F32 DA
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David J. / Virginia Commonwealth University
Publications
Mokler, D J; Robinson, S E; Rosecrans, J A
(1987)
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
Eur J Pharmacol 138:265-8
Comments
Be the first to comment on David Mokler's grant